Marty Felsenthal


Marty has worked exclusively with innovative, disruptive, and rapidly growing healthcare software and services companies for more than 20 years.  He was previously a partner at two leading venture and growth capital firms focused on this sector -- Salix Ventures and HLM Venture Partners - and also worked with Madison Dearborn Partners earlier in his career.  He has led investments in companies such as TelaDoc (NYSE: TDOC); Change Healthcare (acquired by Emdeon); Aperio (acquired by Leica Biosystems); Titan Health (acquired by United Surgical Partners); US Renal Care (acquired by Leonard Green);  Payerpath (acquired by Misys/Allscripts); Vantage Oncology (acquired by McKesson); NovoLogix (acquired by CVS Health); VeriCare (acquired by MedOptions); OnShift; ClearData Networks; Infusion Express; and MDLIVE.  Marty also serves as an adviser to the California Healthcare Foundation Innovation Fund.  Marty received his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.

Bruce Crosby


Bruce has spent 25 years as a healthcare executive, entrepreneur, and venture and growth stage investor. He has helped build and invested in a number of high growth, successful healthcare software and services companies with revenues ranging from $10 million to $700 million. Bruce's executive roles have all been focused on the growth of these businesses and included senior responsibility for Business Development, Corporate Development, Product Development, Strategy, Sales, and Marketing. He has served customers in many of the largest sectors within healthcare services. 

Bruce's executive roles have been with Compassus, the nation's 3rd largest hospice and palliative care company; Healthways (NASDAQ: HWAY), the nation's largest independent disease and population health management company and largest Medicare Advantage consumer services benefit provider; and The Advisory Board Company (NASDAQ: ABCO), one of the nation's largest health system best-practice research and software businesses. At JPMorgan Partners, Bruce led investments in Accordant Health Services (acquired by AdvancePCS) and National Surgical Care (acquired by Amsurg), and played a key role in the buyout of the initial hospitals to form IASIS Healthcare (acquired by TPG Capital). At Healthways, he drove investments in D2Hawkeye (acquired by Verisk Analytics) and iTriage (acquired by Aetna).  Bruce serves on the boards of Spero Health and Contessa Health.  Bruce received his AB from Princeton University and his MBA from the Wharton School at The University of Pennsylvania.

Saurabh Bhansali


Saurabh has spent his career working with innovative healthcare services and software companies.  Most recently, Saurabh helped build and lead investments for Humana Health Ventures, the venture capital arm at one of the nation’s leading healthcare companies and second largest Medicare Advantage insurer. At Humana (NYSE: HUM), Saurabh led investments in Aspire Health (acquired by Anthem), an important and leading provider of palliative and end-of-life care management, and Circulation Health (acquired by Logisticare), a patient-centric digital patient transportion platform, and was also actively involved with investments in Omada Health and Livongo Health, both first-movers in digital health management in the areas of pre-diabetes and Type II diabetes, respectively.  In addition to his formal investing responsibilities, he was also a key member in driving discovery and innovation efforts across Humana’s enterprise, developed best practices to drive the right innovative companies and themes throughout the company, and was recognized as a Rising Star by the Global Corporate Venturing organization in 2017.  Prior to Humana, Saurabh was on the investing team at HLM Venture Partners, where he was involved in investments in Binary Fountain, ClearDATA Networks, and AbleTo and served as a Board Observer at Vericare Management (acquired by MedOptions) and Imagine Health. He also held roles at Ferrer Freeman & Co. as part of the investing team, at Bank of America Merrill Lynch as an investment banker, and at Pfizer as part of the mergers, acquisitions and licensing team.  Saurabh serves as a board observer at Spero Health, Contessa Health, and Jvion.  He received his BA from Northwestern University and his MBA from The Wharton School at the University of Pennsylvania.

Grant Blevins Headshot.jpg

Grant Blevins

Senior Associate

Grant has spent his career investing exclusively into innovative healthcare companies.  Prior to joining Health Velocity Capital, Grant was an investor with FCA Venture Partners, one of Nashville’s most established healthcare venture capital firms.  During his time at FCA (and the seed fund of FCA, Dioko Ventures), he sourced investments in HealthiPASS, MediQuire, Vericred, RubiconMD, and QueueDr and was involved with notable investments in Saferide Health, One Medical Passport, ShiftWizard, Healthy Bytes, and others.  At FCA, Grant played a lead role in all deal sourcing and also led research efforts for the firm which helped to develop investment theses. Grant received his Bachelor of Business Administration in Entrepreneurship from Belmont University. 

JennyGuyton Headshot.jpg

Jenny Guyton

Senior Associate

Jenny has spent her career driving innovation in health care services and technology as an operator and investor.  Most recently, Jenny led various acquisitions and de novo new product development initiatives at The Advisory Board Company (NASDAQ:  ABCO), a market-leading health care research, consulting, and technology company.  While there, she was active in the acquisition of Clinovations, a highly successful EMR optimization consulting and services organization, and the development and launch of The Advisory Board’s self-service data analytics platform.  She later spearheaded The Advisory Board’s strategic partnership program and led special projects for the company’s technology business, including a strategic reorganization of the business.  Prior to The Advisory Board, Jenny worked in investment banking focused on mergers and acquisitions.  She has also held positions at Town Hall Ventures, Flare Capital as a Flare Capital Fellow, Bridgewater Associates, and Google (NASDAQ: GOOG).  Jenny received her BA in Ethics, Politics, and Economics from Yale University and her MBA from The Wharton School.  At Wharton, Jenny graduated from its Health Care Management program and received the Howard E. Mitchell Fellowship.

Julie Foster.jpg



Julie is the administrator for Health Velocity Capital and is responsible for making our trains run on time.  She has been working in the venture capital industry since 1999 at firms including Salix Ventures, De Novo Ventures, and HLM Venture Partners.

David Felsenthal

Founding Advisory Board Member

David Felsenthal serves as president of The Advisory Board Company (NASDAQ:  ABCO) a global research, technology, and consulting firm that serves over 4,100 leading organizations across health care and higher education.  Having first joined the firm in 1992, he previously served as The Advisory Board Company’s chief operating officer and chief financial officer and has also held roles in both new product development and research.  He formerly served as director of business development and special assistant to the CEO/CFO at Vivra Specialty Partners, a private health care services and technology firm.

Doug Ghertner

Founding Advisory Board Member

Doug Ghertner is the former Chief Sales Officer and President, Engagement Solutions, of Emdeon (now Change Healthcare).  Previously, he was CEO of Change Healthcare prior to its acquisition by Emdeon.  Change Healthcare was a leading provider of member engagement and cost transparency solutions sold to health plans and large self-insured employers.  During his tenure, Change Healthcare increased the number of individuals who received its services from 20,000 to more than 15 million.  Prior to joining Change Healthcare as CEO, Doug served in a variety of leadership roles with CVS, including SVP of Client Solutions.

Ben Leedle

Founding Advisory Board Member

Ben Leedle served as CEO of Healthways (NASDAQ:  HWAY) from 2003 until 2015.  During his tenure as CEO, Healthways increased revenue from $165 million to $770 million and became the leading independent disease management, population health management, consumer engagement, and senior-focused consumer services company in healthcare.  Ben joined Healthways in 1985 initially supporting early models for advancing population health for people with diabetes. Over his 30-year career with the company, he rose in the organization as a leader and manager of business development, product management, and operations – serving as the company’s Chief Operating Officer - before being elected President & Chief Executive Officer, and Board Director of Healthways in 2003.


Kent Marquardt

Founding Advisory Board Member

Kent is the former Executive Vice President and Chief Financial Officer of Premera Blue Cross, where he was responsible for finance, corporate informatics, healthcare economics, innovation, and strategic investments.  As part of these efforts, he identified and sponsored a number of important and successful healthcare innovators and played a key role as an early customer at companies such as Landmark Health, Teladoc, and MOBE.  He previously served as a partner with KPMG Peat Marwick, as Chief Financial Officer for PriMed Management Consulting (Hill Physician Management Company), as CEO of American Dental Specialists, and Chief Operating Officer and Chief Financial Officer of the western operations for MedPartners, the nation’s then largest publicly held physician practice management company.  He currently serves as an independent board of director at Landmark Health and Cardinal Analytics and as an advisory for BookMD.

Scott Powder.png

Scott Powder

Founding Advisory Board Member

Scott Powder is responsible for strategy, innovation and long-range strategic planning and business development activities, including mergers, acquisitions and strategic partnerships for Advocate Aurora Health, one of the nation’s 10 largest not-for-profit health systems with more than 500 sites of care, 8,100 physicains, and 70,000 team members.  A national strategic thought leader, Scott has served at Advocate Health Care for 24 years and has held a number of business development and strategy positions during his tenure, including Vice President Business Development for Lutheran General Hospital, Vice President Business Development for Advocate Medical Group, and Vice President System Strategy and Development.

He currently serves on the Board of Directors for Advocate Physician Partners, Advocate Home Products, and Advocate’s joint venture with SCA.  Scott also serves as a strategic advisor to Leidos, a Washington DC-based military and health IT firm.  Scott earned his master’s degree from the Kellogg Graduate School of Management at Northwestern University and his bachelor’s degree in International Relations from Michigan State University.

Mark Smith, M.d.

Founding Advisory Board Member

Mark Smith, MD serves as Co-chair of the Health Care Payment Learning & Action Network’s Guiding Committee. He is Visiting Professor, University of California at Berkeley, and Clinical Professor of Medicine, University of California at San Francisco.  He was the Founding President and former Chief Executive Officer of the California HealthCare Foundation (CHCF).  Previously, Mark was Executive Vice President at the Henry J. Kaiser Family Foundation where he oversaw programs in HIV, reproductive health, and the health care marketplace. Prior to that, he was a faculty member at the Johns Hopkins Schools of Medicine and of Public Health. Dr. Smith was elected a member of the Institute of Medicine (IOM) in 2001 and chaired the IOM’s Committee on the Learning Healthcare System, which produced the 2012 report, Best Care at Lower Cost.  He has served on the board of the National Business Group on Health, the performance measurement committee of the National Committee for Quality Assurance, and the editorial board of the Annals of Internal Medicine.

lew trowbridge


Lew is the former President and COO of Blue Cross Blue Shield of Nebraska, where he also served as Chief Financial Officer and Treasurer. Prior to joining Blue Cross Blue Shield of Nebraska, Lew was the CEO of World Marketing, Inc., a private equity roll-up in the newspaper and direct marketing arena, and the CEO of The SilverStone Group, Inc., a large regional insurance brokerage and human resource/actuarial consulting firm. He was also a Managing Partner at KPMG. Lew currently serves as a board member of Think Whole Person Primary Care LLC, a first of its kind, integrated care delivery enterprise with 46,000 patients and 24 independent primary care physicians; of a $900 million regional bank based in Omaha; and is a trustee of the W. David Scott Foundation. Lew was previously on the boards of TriWest Health Alliance, which administered the Tricare contract for the western 21 states; HTH (now GeoBlue), an insurance company offering international health insurance products for ex-patriots, students and other overseas travelers; Nebraska Medical Center; and the Peter Kiewit Institute. Lew was also the co-founder of the Blue Investment Collaborative, a coalition of 10 like-minded Blue plans who meet regularly to discuss collaborative private equity investment opportunities.

Sally Welborn_12_17_2014 Headshot.jpg

Sally Wellborn

Founding Advisory Board member

Sally currently advises health care organizations, entrepreneurs, and others in the health care and employee benefits arenas, and works extensively as the Executive Advisor to the Employer Health Innovation Roundtable. Prior to her current activities, she was most recently the Senior Vice President of Global Benefits for Walmart Stores, Inc. where she was responsible for overseeing the global benefits programs for Walmart’s more than 2.2 million associates and their families in twenty-eight countries. Prior to joining Walmart, she was senior vice president, Corporate Benefits for Wells Fargo & Company.  Before that, her career includes consulting with large employers in all areas of benefits strategy and health care optimization when she was with HCIA, Inc. and William M. Mercer, Inc. She also worked at Aetna as a relationship manager and at Union Bank as the Vice President of Benefits.

Sally currently serves on the Board of Directors of Truveris, Inc., the Leapfrog Group, and Vivante Health.  She also serves on the Advisory Board for the Penn Center for Health Incentives and Behavioral Economics. 

Frank Williams

Founding Advisory Board Member

Frank Williams serves as Chief Executive Officer of Evolent Health (NYSE:  EVH). Evolent works with leading health systems to achieve superior clinical and financial results through value-based care transformation. The company employs over 1,000 professionals across its corporate and client locations in 25 markets nationwide. Backed by capital, asset and intellectual property contributions from UPMC Health Plan and The Advisory Board Company, Evolent completed an initial public offering in June of 2015. Prior to Evolent, Frank served as Chief Executive Officer and Chairman of The Advisory Board Company, a global research, technology, and consulting firm that serves over 4,100 leading organizations across health care and higher education. During Frank’s tenure as both its Chairman and CEO, The Advisory Board completed an initial public offering and grew to $450M+ in annual revenues with over 2,500 employees and $2B+ in market capitalization. Frank previously served as the President of MedAmerica OnCall, the President of Vivra Orthopedics and as a Consultant for Bain & Co.